ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO728

Screening for Osteoporosis Represents a Missed Opportunity in Women with ESRD

Session Information

Category: Women’s Health and Kidney Diseases

  • 2000 Women’s Health and Kidney Diseases


  • Kazory, Amir, University of Florida, Gainesville, Florida, United States
  • Phen, Samuel, University of Florida, Gainesville, Florida, United States
  • Bozorgmehri, Shahab, University of Florida, Gainesville, Florida, United States
  • Ozrazgat-Baslanti, Tezcan, University of Florida, Gainesville, Florida, United States
  • Sattari, Maryam, University of Florida, Gainesville, Florida, United States

Women with end-stage renal disease (ESRD) treated with hemodialysis (HD) have increased morbidity and mortality, and shorter life expectancy. In fact, the survival advantage that women have over men in the general population is markedly decreased in the HD population. The purpose of this study was to explore age-appropriate preventive care for women with ESRD on maintenance HD.


We performed a cross-sectional survey of adult patients with ESRD undergoing HD in two outpatient dialysis centers at the University of Florida. Interviews were conducted using a survey instrument that contained questions on demographic information, types of health care providers, and a number of preventive measures. We used United States Preventive Services Task Force (USPSTF) guidelines to determine eligibility and completion of screening for breast and cervical cancers as well as osteoporosis.


Of the 132 patients who participated in this study, 66 (50%) were female. The average age of women was 60 (range = 22-84). The majority (95.5%, n=63) reported having a primary care provider (PCP). Out of the eligible patients, 81.4% (35/43) reported being up-to-date on breast cancer screening, 75% (33/44) on cervical cancer screening, and 16.7% (4/24) on osteoporosis screening. Having a PCP was associated with a trend towards higher adherence with preventive care measures.


Our study identifies “osteoporosis screening” as an opportunity to improve preventive care of women with ESRD treated with maintenance HD. The rates of osteoporosis screening were found to be even lower than the general population (i.e. 25%) in this cohort. Interestingly, women reported higher rates of screening for malignancies of breast and cervix compared to the general population. While there has been a shifting paradigm in diagnosis and management of osteoporosis in patients with ESRD, future studies are needed to identify patient and provider characteristics associated with higher likelihood of adherence to age-appropriate preventive care for female patients with ESRD.